Ideagen PLC Exercise of Options (7455C)
October 20 2015 - 2:00AM
UK Regulatory
TIDMIDEA
RNS Number : 7455C
Ideagen PLC
20 October 2015
Ideagen plc
("Ideagen" or the "Company")
Exercise of Options and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information
Management Software to highly regulated industries, announces that
it has allotted 1,028,750 new ordinary shares of 1 penny each in
the capital of the Company ("Ordinary Shares") following the
exercise of share options.
Application has been made to the London Stock Exchange for the
1,028,750 new Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 23 October
2015.
After Admission, the total number of Ordinary Shares in issue
will be 178,858,428 and the total number of voting rights will
therefore be 178,858,428. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
Enquiries:
Ideagen Plc Tel: 01629 699100
David Hornsby, Chief Executive
Graeme Spenceley, Finance
Director
finnCap (Nominated Adviser Tel: 020 7220 0500
and Broker)
Stuart Andrews / James Thompson
(Corporate Finance)
Stephen Norcross (Corporate
Broking)
Alma PR
Hilary Buchanan Tel: 07515 805218
Josh Royston Tel: 07780 901979
About Ideagen plc
Ideagen is a UK company quoted on the AIM market of the London
Stock Exchange (Ticker: IDEA.LN). Ideagen is a supplier of
compliance based Information Management software with operations in
the UK, the United States and the Middle East. The Company
specialises in eGRC (Enterprise Governance, Risk and Compliance)
and Healthcare solutions for organisations operating within highly
regulated industries. With an excellent portfolio of software
products, Ideagen is able to provide complete content lifecycle
solutions that enable organisations to meet their Regulatory and
Quality Compliance standards, helping them to reduce costs and
improve efficiency.
The Group has a customer base of over 1,500 organisations using
the Ideagen suite of products, including many blue chip names such
as BAE Systems, Emirates, Shell and the European Central Bank as
well as 150 hospitals in the UK and US.
For further information please visit www.ideagenplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEMLBFTMBJBBTA
(END) Dow Jones Newswires
October 20, 2015 02:00 ET (06:00 GMT)
Ideagen (LSE:IDEA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ideagen (LSE:IDEA)
Historical Stock Chart
From Apr 2023 to Apr 2024